<h1>Global health experts call for including tobacco harm reduction in policy to cut costs, curb illicit markets, and protect choice</h1> A consumer advocacy group convened physicians, researchers and advocates from multiple countries to critique the WHO Framework Convention on Tobacco Control and urge formal integration of tobacco harm reduction into national and international policy. Presenters highlighted economic burdens from tobacco-related disease, modeled potential healthcare cost savings from partial switching to reduced-risk products, and warned that restrictive or inconsistent regulations and punitive taxation can fuel illicit markets and cross-border purchases. The group recommended evidence-based, risk-proportionate taxation and regulatory frameworks that recognize consumer choice while aligning public health objectives with economic efficiency.